Frimel TN, Sinacore DR, Villareal DT
Back Turton, MD, O'Shea, D, Gunn, et al (4 Jan 1996) 'A role for glucagon-like peptide-1 in the central regulation of feeding', Nature , 379, 69-72
*Eligible patients with a BMI of 30, or 27 with weight-related comorbidities, lost an average of 8% of their body weight (-18.5 lbs) in a 56-week clinical trial evaluating 3.0 mg liraglutide, when combined with a reduced-calorie diet and increased physical activity
Staining was performed with Anti-GLP-1R Antibody (A83537) at 10g/ml for 1 hour and Alexa Fluor 488 secondary antibody at 1g/ml
doi: 10.1056/NEJMoa1607141 43 MarsoS
This creates a frustrating illusion of a stall when fat loss is actually continuing normally underneath the constipation weight